Assessment of MDD Management in Andalusia

MDD Management Strategies Clinical Trial

— PismaEP  

Official title:

Assessment of MDD Management Strategies in Andalusia: A Sub-analysis of the PismaEP Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01510886
• Other study ID #: NIS-NES-XXX-2011/3
• Secondary ID: PismaEP
• Status: Completed
• Phase: N/A
• First received: January 12, 2012
• Last updated: August 12, 2014
• Start date: June 2012
• Est. completion date: September 2013

Study information

• Verified date: August 2014
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Spanish Agency of Medicines
• Study type: Observational

Clinical Trial Summary

The main objectives of this study are to describe medical professionals responsible of the management of patients with MDD in a representative region of Andalusia (in terms of type of sites managing the disease, and referral to SC criteria); Describe MDD patient characteristics at inclusion in the PISMA-Ep Study; and to evaluate those factors associated to a higher incidence of referral from PC to SC.

Description:

Assessment of MDD management strategies in Andalusia: A Sub-analysis of the PismaEP Study

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5309
• Est. completion date: September 2013
• Est. primary completion date: September 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• MDD Diagnosis Participants of the PismaEP study 18 yo. or older

Exclusion Criteria:

• No specific exclusion criteria

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• MDD Management Strategies

Locations

Country	Name	City	State
Spain	Research Site	Granada

Sponsors (1)

Lead Sponsor	Collaborator
AstraZeneca

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Visits to Primary Care		From Jan 2010 to Jan 2011	No
Primary	Number of Visits to Secondary Care		From Jan 2010 to Jan 2011	No
Primary	Number of Referrals		From Jan 2010 to Jan 2011	No
Secondary	Demographics		From Jan 2010 to Jan 2011	No
Secondary	Type of site		From Jan 2010 to Jan 2011	No
Secondary	Type of therapeutic strategy		From Jan 2010 to Jan 2011	No
Secondary	Type of disease		From Jan 2010 to Jan 2011	No
Secondary	Severity of disease		From Jan 2010 to Jan 2011	No

External Links

•   NIS-NES-XXX-2011-3 Clinical Study Report Synopsis